{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:22:14Z","timestamp":1788808934430,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-80705-7","type":"journal-article","created":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T10:02:13Z","timestamp":1732442533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Single center evaluation of sensitivity and specificity of CellDetect assay in early bladder cancer patients"],"prefix":"10.1038","volume":"14","author":[{"given":"Wenbo","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiling","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,24]]},"reference":[{"key":"80705_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk, M., Burger, M. & Capoun, O. European Association of Urology Guidelines on non-muscle-invasive bladder Cancer (Ta, T1, and carcinoma in situ). Eur. Urol. 81, 75 (2022).","journal-title":"Eur. Urol."},{"key":"80705_CR2","first-page":"497","volume":"39","author":"E Shkolyar","year":"2021","unstructured":"Shkolyar, E., Zhao, Q. & Mach, K. E. Bladder cancer risk stratification using a urinary mRNA biomarker panel - A path towards cystoscopy triaging. Uro Onc. 39, 497 (2021).","journal-title":"Uro Onc"},{"key":"80705_CR3","doi-asserted-by":"publisher","first-page":"21816","DOI":"10.1038\/s41598-023-49167-1","volume":"13","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Identification and validation of telomerase related lncRNAs signature to predict prognosis and tumor immunotherapy response in bladder cancer. Sci. Rep. 13, 21816 (2023).","journal-title":"Sci. Rep."},{"key":"80705_CR4","first-page":"1","volume":"13","author":"K Niko","year":"2022","unstructured":"Niko, K., Ivan, P., Andreja, Z. & Nadja, K. V. Clinical Evaluation of Two Non-invasive Genetic Tests for Detection and Monitoring of Urothelial Carcinoma: validation of UroVysion and xpert bladder Cancer detection test. Front. Genet. 13, 1 (2022).","journal-title":"Front. Genet."},{"key":"80705_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02683-4","volume":"19","author":"H Yosuke","year":"2021","unstructured":"Yosuke, H. et al. Diagnostic performance of Oncuria, a urinalysis test for bladder cancer. J. Transl Med. 19, 1 (2021).","journal-title":"J. Transl Med."},{"key":"80705_CR6","first-page":"4","volume":"4","author":"Y Glickman","year":"2016","unstructured":"Glickman, Y., Davis, N. & Nativ, O. Combining color and morphology to detect low grade urothelial cell carcinoma in urine specimens. Arch. Can. Res. 4, 4 (2016).","journal-title":"Arch. Can. Res."},{"key":"80705_CR7","first-page":"6","volume":"41","author":"KS Hila","year":"2023","unstructured":"Hila, K. S. et al. Performance of CellDetect for detection of bladder cancer: comparison with urine cytology and UroVysion. UrolOncol 41, 6 (2023).","journal-title":"UrolOncol"},{"key":"80705_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"CC Guo","year":"2020","unstructured":"Guo, C. C., Bondaruk, J., Yao, H., Wang, Z. & Czerniak, B. Assessment of luminal and basal phenotypes in bladder cancer. Sci. Rep. 10, 1 (2020).","journal-title":"Sci. Rep."},{"key":"80705_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s12935-021-02169-3","volume":"21","author":"D Shang","year":"2021","unstructured":"Shang, D., Liu, Y. & Xu, X. Diagnostic value comparison of CellDetect, fluorescent in situ hybridization (FISH), and cytology in urothelial carcinoma. Cancer Cell. Int. 21, 465 (2021).","journal-title":"Cancer Cell. Int."},{"key":"80705_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13148-016-0303-5","volume":"9","author":"A Feber","year":"2017","unstructured":"Feber, A., Dhami, P. & Dong, L. UroMark-a urinary biomarker assay for the detection of bladder cancer. Clin. Epigenet.. 9, 8 (2017).","journal-title":"Clin. Epigenetics"},{"key":"80705_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-022-10244-9","volume":"22","author":"Q Huang","year":"2022","unstructured":"Huang, Q. et al. Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030. BMC Cancer. 22, 1 (2022).","journal-title":"BMC Cancer"},{"key":"80705_CR12","doi-asserted-by":"publisher","first-page":"19227","DOI":"10.1038\/s41598-023-46091-2","volume":"13","author":"A Janev","year":"2023","unstructured":"Janev, A. et al. Human amniotic membrane inhibits migration and invasion of muscle-invasive bladder cancer urothelial cells by downregulating the FAK\/PI3K\/Akt\/mTOR signalling pathway. Sci. Rep. 13, 19227 (2023).","journal-title":"Sci. Rep."},{"key":"80705_CR13","first-page":"601","volume":"38","author":"T Hermanns","year":"2020","unstructured":"Hermanns, T., Savio, A. J. & Olkhov-Mitsel, E. A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade. Uro Oncol. 38, 601 (2020).","journal-title":"Uro Oncol."},{"key":"80705_CR14","doi-asserted-by":"publisher","first-page":"8305","DOI":"10.1038\/s41598-019-44504-9","volume":"9","author":"S Pak","year":"2019","unstructured":"Pak, S. et al. Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer. Sci. Rep. 9, 8305 (2019).","journal-title":"Sci. Rep."},{"key":"80705_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41419-021-04296-1","volume":"12","author":"W Luo","year":"2021","unstructured":"Luo, W. et al. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging mir-129-5p in bladder cancer. Cell. Death Dis. 12, 1043 (2021).","journal-title":"Cell. Death Dis."},{"key":"80705_CR16","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/bju.15382","volume":"129","author":"T Lebret","year":"2022","unstructured":"Lebret, T., Pignot, G. & Colombel, M. Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test. BJU Int. 129, 356 (2022).","journal-title":"BJU Int."},{"key":"80705_CR17","first-page":"5538","volume":"7","author":"S Yu","year":"2014","unstructured":"Yu, S., Meng, Q., Hu, H. & Zhang, M. Correlation of anxa1 expression with drug resistance and relapse in bladder cancer. Int. J. Cli Exp. Patho. 7, 5538 (2014).","journal-title":"Int. J. Cli Exp. Patho"},{"key":"80705_CR18","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41550-019-0798-8","volume":"3","author":"L Gu","year":"2019","unstructured":"Gu, L. et al. Observations of a pre-merger shock in colliding clusters of galaxies. Nat. Astron. 3, 838 (2019).","journal-title":"Nat. Astron."},{"key":"80705_CR19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/cncr.33479","volume":"127","author":"C Printz","year":"2021","unstructured":"Printz, C. Liquid biopsy test appears better at detecting bladder cancer than urine cytology. Cancer 127, 663 (2021).","journal-title":"Cancer"},{"key":"80705_CR20","first-page":"CD","volume":"9","author":"JC Dudley","year":"2018","unstructured":"Dudley, J. C., Schroers-Martin, J. & Lazzareschi, D. V. Detection and surveillance of bladder Cancer using urine tumor DNA. Can. Dis. 9, CD\u201318 (2018).","journal-title":"Can. Dis."},{"key":"80705_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaa047","author":"M Zhou","year":"2021","unstructured":"Zhou, M. et al. Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer. Brief. Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbaa047 (2021).","journal-title":"Brief. Bioinform"},{"key":"80705_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3233\/CBM-200072","volume":"30","author":"S Hussein","year":"2021","unstructured":"Hussein, S. et al. SATB-1 and Her2 as predictive molecular and immunohistochemical markers for urothelial cell carcinoma of the bladder. Cancer Biomark. 30, 249 (2021).","journal-title":"Cancer Biomark."},{"key":"80705_CR23","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1038\/s41598-024-53272-0","volume":"14","author":"Z Song","year":"2024","unstructured":"Song, Z. et al. A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer. Sci. Rep. 14, 3198 (2024).","journal-title":"Sci. Rep."},{"key":"80705_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-019-1556-x","volume":"573","author":"G Miniutti","year":"2019","unstructured":"Miniutti, G. et al. Nine-hour X-ray quasi-periodic eruptions from a low-mass black hole galactic nucleus. Nature 573, 381 (2019).","journal-title":"Nature"},{"key":"80705_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/03915603221150036","volume":"90","author":"\u00d6 Y\u00fcksel","year":"2023","unstructured":"Y\u00fcksel, \u00d6., Tosun, \u00c7. & G\u00fcmr\u00fck\u00e7\u00fc, G. What is the role of CellDetect\u00ae in detecting and monitoring bladder cancer? Urologia90, 261 (2023).","journal-title":"Urologia"},{"key":"80705_CR26","doi-asserted-by":"publisher","unstructured":"Springer, S. U., Chen, C. H. & Pena, M. D. Correction: non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy. eLife Sci. 7 . https:\/\/doi.org\/10.7554\/eLife.43237 (2018).","DOI":"10.7554\/eLife.43237"},{"key":"80705_CR27","doi-asserted-by":"publisher","unstructured":"Davis, N., Shtabsky, A., Lew, S. A. & Novel Urine-based assay for bladder Cancer Diagnosis: multi-institutional validation Study.Eur urol focus, S2405456916301493. https:\/\/doi.org\/10.1016\/j.euf (2016).","DOI":"10.1016\/j.euf"},{"key":"80705_CR28","doi-asserted-by":"publisher","first-page":"e751","DOI":"10.1016\/S1569-9056(16)60753-4","volume":"15","author":"O Yossepowitch","year":"2016","unstructured":"Yossepowitch, O. Colour and morphology combination for detection of low grade urothelial cancer cells Multicenter validation study. Eur. Urol. Suppl. 15, e751 (2016).","journal-title":"Eur. Urol. Suppl."},{"key":"80705_CR29","first-page":"425","volume":"54","author":"RD Michelle","year":"2022","unstructured":"Michelle, R. D., Katherine, L., Cynthina, K. B. & Girish, S. The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes. Pathology 54, 425 (2022).","journal-title":"Pathology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80705-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80705-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80705-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T11:01:53Z","timestamp":1732446113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80705-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,24]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80705"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80705-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,24]]},"assertion":[{"value":"3 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The inclusion of patients complies with the Helsinki Declaration and has been approved by the Clinical Research Ethics Committee of Ningbo Urology and Nephrology Hospital. Written informed consent was obtained from all subjects involved in the study before their participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}],"article-number":"29099"}}